Orthofix International (OFIX) Tops Q4 EPS by 25c, Revenues Beat; Offers FY21 EPS/Revenue Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Orthofix Reports Fourth Quarter and Fiscal Year 2020 Results
February 26, 2021 7:00 AM ESTFourth quarter net sales of $117.6 million, within 3% of our 2019 results US Spine implant sales grew 11% compared to fourth quarter 2019, driven by record M6-C artificial cervical disc performance Strong cash flow performance in the quarter, free cash flow of $17.9 million FITBONE® intramedullary lengthening and deformity system receives FDA clearance for pediatric indication
LEWISVILLE, Texas--(BUSINESS WIRE)-- Orthofix Medical Inc. (NASDAQ: OFIX) today reported its financial results for the fourth quarter and fiscal year ended December 31, 2020. Net sales for... More
